Synthesis and inhibitory activity of ubiquinone-acetogenin hybrid inhibitor with bovine mitochondrial complex I

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 14, 2003, Pages 2385-2388

  Yabunaka, Hiromi ^a   Abe, Masato ^a   Kenmochi, Atsushi ^a   Hamada, Takeshi ^a   Nishioka, Takaaki ^a   Miyoshi, Hideto ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOGENIN; GAMMA LACTONE DERIVATIVE; Q ACETIGENIN; UBIQUINOL CYTOCHROME C REDUCTASE; UBIQUINONE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS;

BOVINAE;

EID: 0038003853     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00439-6     Document Type: Article

References (24)

1. Zeng L., Ye Q., Oberlies N.H., Shi G., Gu Z.-M., He K., McLaughlin J.L. Nat. Prod. Rep. 13:1996;275.
2. Alali F.Q., Liu X.X., McLaughlin J.L. J. Nat. Prod. 62:1999;504.
3. Degli Esposti M., Ghelli A., Ratta M., Cortes D., Estornell E. Biochem. J. 301:1994;161.
4. Friedrich T., Van Heek P., Leif H., Ohnishi T., Forche E., Kunze B., Jansen R., Trowitzsch-Kienast W., Höfle G., Reichenbach H., Weiss H. Eur. J. Biochem. 219:1994;691.
5. Okun J.G., Lümmen P., Brandt U. J. Biol. Chem. 274:1999;2625.
6. Miyoshi H. J. Bioenerg. Biomembr. 33:2001;223.
7. Hoppen S., Emde U., Friedrich T., Grubert L., Koert U. Angew. Chem. Int. Ed. 39:2000;2099.
8. 50 values of mucocin and squamocin D are about 30- and 8-fold larger than that of rotenone, the inhibitory potency of which is about 1/10th that of bullatacin (refs 4-6).
9. Ohshima M., Miyoshi H., Sakamoto K., Takegami K., Iwata J., Kuwabara K., Iwamura H., Yagi T. Biochemistry. 37:1998;6436.
10. Motoyama T., Yabunaka H., Miyoshi H. Bioorg. Med. Chem. Lett. 12:2002;2089.
11. Yamaguchi M., Hirano I. Tetrahedron Lett. 24:1983;391.
12. Hoye T.R., Ye Z. J. Am. Chem. Soc. 118:1996;1801.
13. Sonogashira K., Tohda Y., Hagihara N. Tetrahedron Lett. 16:1975;4467.
14. + calcd 692.5227, found 692.5247.
15. Kuwabara K., Takada M., Iwata J., Tatsumoto K., Sakamoto K., Iwamura H., Miyoshi H. Eur. J. Biochem. 267:2000;2538.
16. 50 values were averaged from two independent experiments.
17. Miyoshi H., Ohshima M., Shimada H., Akagi T., Iwamura H., McLaughlin J.L. Biochim. Biophys. Acta. 1365:1998;443.
18. Takada M., Kuwabara K., Nakato H., Tanaka A., Iwamura H., Miyoshi H. Biochim. Biophys. Acta. 1460:2000;302.
19. Taking into consideration the amphiphilic character of compound 2, it is very likely that the apparent inhibition was brought about by nonspecific perturbation of the membrane (or the enzyme) structure due to high concentration.
20. Schuler F., Yano T., Di Bernardo S., Yagi T., Yankovskaya V., Singer T., Casida J.E. Proc. Natl. Acad. Sci. U.S.A. 96:1999;4149.
21. Nakamaru-Ogiso E., Sakamoto K., Matsuno-Yagi A., Miyoshi H., Yagi T. Biochemistry. 42:2003;746.
22. d value of bullatacin is 2-5 nM (ref 5).
23. Breton J., Boullais C., Berger G., Mioskowski C., Nabedryk E. Biochemistry. 34:1995;11606.
24. Hellwig P., Mogi T., Tomson F.L., Gennis R.B., Iwata J., Miyoshi H., Mäntele W. Biochemistry. 38:1999;14683.